BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Drug Development

  China Drug Administration Approves Epclusa® (Sofosbuvir/Velpatasvir), Gilead’s Pan-Genotypic Treatment for Chronic Hepatitis C Virus Infection

  Gilead Sciences, Inc. announced today that the China Drug Administration (CDA) has approved Epclusa® (sofosbuvir 400 mg/velpatasvir 100 mg) for the treatment of adults with genotype 1-6 chronic hepatitis C virus (HCV) infection.

  May 30, 2018

   · 

  7 min read
• Genetown

  BrainStorm Cell Therapeutics to Provide Corporate Update at the BIO International Convention

  BrainStorm Cell Therapeutics Inc. announced today that the Company will present a corporate overview at the BIO International Convention.

  May 30, 2018

   · 

  2 min read
• Genetown

  PureTech Health to Present at Jefferies 2018 Global Healthcare Conference

  PureTech Health plc announced that Joep Muijrers, Ph.D., Chief Financial Officer at PureTech Health, will present at the Jefferies 2018 Global Healthcare Conference.

  May 30, 2018

   · 

  2 min read
• Business

  AbCellera and Harbour Antibodies Announce Technology Co-Offering Agreement for Next-Generation Fully-Human Antibody Discovery

  Co-offering combines AbCellera’s microfluidic single-cell screening platform with Harbour’s H2L2 transgenic mouse technology to create an end-to-end solution for the discovery of fully-human lead therapeutic antibodies.

  May 30, 2018

   · 

  4 min read
• Pharm Country

  Menopausal Women Staying Silent About Painful Sex - Recent Survey Highlights Knowledge Gap About Treatment Options

  HealthyWomen along with Duchesnay USA announced the results of a survey* evaluating the experience of postmenopausal women with one of the most common and troubling symptoms of menopause: painful sex.

  May 30, 2018

   · 

  5 min read
• Biotech Bay

  Aimmune Therapeutics Announces New Pan-European Study Showing Significant Psychosocial Burden Associated With Peanut Allergy

  Aimmune Therapeutics, Inc. announced that data from a new study on the psychosocial burden of peanut allergy in European countries were presented at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2018 in Munich.

  May 30, 2018

   · 

  6 min read
• Business

  TapImmune to Present at 2018 Sachs Associates Immuno-Oncology BD&L and Investment Forum

  TapImmune Inc. will participate in a panel discussion and give a company presentation at the 2018 Sachs Associates Immuno-Oncology BD&L and Investment Forum.

  May 30, 2018

   · 

  3 min read
• Nutrition Society of China and Russia Jointly Promote Dairy Industry Development

  China-Russia Nutrition Forum was successfully held in Moscow, taking “World Digestive Health Day” as the theme.

  May 30, 2018

   · 

  2 min read
• Business

  Teleflex to Present at the 39th Annual Goldman Sachs Global Healthcare Conference

  Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated, is scheduled to speak at the 39th Annual Goldman Sachs Global Healthcare Conference

  May 30, 2018

   · 

  1 min read
• Business

  SOC Telemed Selects Trevelino/Keller to Solidify New Brand Identity for Category Leader

  Trevelino/Keller has been engaged by SOC Telemed, the leader in hospital-based telemedicine.

  May 30, 2018

   · 

  4 min read